Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.26 USD | -1.36% | -21.00% | -39.55% |
04-30 | Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating | MT |
04-26 | Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating | MT |
Evolution of the average Target Price on Accolade, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Accolade, Inc.
Wells Fargo Securities | |
Morgan Stanley | |
Stifel Nicolaus | |
Leerink Partners | |
Raymond James | |
Piper Sandler | |
Canaccord Genuity | |
Truist Securities | |
Credit Suisse | |
Needham & Co. | |
BofA Securities | |
DA Davidson | |
Guggenheim | |
Stephens Inc. | |
Jefferies & Co. | |
Berenberg Bank | |
Goldman Sachs | |
SVB Securities LLC | |
BTIG | |
SVB Leerink | |
Baird |
EPS Revisions
- Stock Market
- Equities
- ACCD Stock
- Consensus Accolade, Inc.